跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
磷/碳酸氢钠血滤置换液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Hemofiltration Replacement Fluid of Sodium Bicarbonate and Phosphate
Approved
化学药品
Hemofiltration Replacement Fluid of Sodium Bicarbonate and Phosphate
Baxter Holding BV
🇨🇳 National Medical Products Administration
Approval Date
Mar 8, 2022
Approval ID
8ElyvZw4R1c
Company
Baxter Holding BV
Type
化学药品
Approval Details
Approval Id
8ElyvZw4R1c
Approval Number
国药准字HJ20220016
Generic Name
磷/碳酸氢钠血滤置换液
Generic Name En
Hemofiltration Replacement Fluid of Sodium Bicarbonate and Phosphate
Drug Type
化学药品
Dosage Form
注射剂
Strength
5000ml
Reg Date
2022-03-08
Expired Date
2027-03-07
Company Name
Baxter Holding BV
Production Company Name
BIEFFE MEDITAL SPA
Company Detail Path
/organization/baxter-holding-bv
Production Company Detail Path
/organization/bieffe-medital-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 8, 2022
Approval ID
8ElyvZw4R1c
Type
化学药品
Back to NMPA Approvals